• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 - 2024
• Five Forces Analysis
o Five forces analysis 2019 & 2024
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Standalone SPECT - Market size and forecast 2019-2024
o Hybrid SPECT - Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Cardiology - Market size and forecast 2019-2024
o Oncology - Market size and forecast 2019-2024
o Neurology - Market size and forecast 2019-2024
o Others - Market size and forecast 2019-2024
o Market opportunity by Application
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2019-2024
o Europe - Market size and forecast 2019-2024
o Asia - Market size and forecast 2019-2024
o ROW - Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Bruker Corp.
o DDD-Diagnostic AS
o Digirad Corp.
o General Electric Co.
o Koninklijke Philips NV
o Mediso Ltd.
o MiE GmbH
o MILabs BV
o Siemens Healthineers AG
o Spectrum Dynamics Medical Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global - Market size and forecast 2019 - 2024 ($ million)
• 14: Global market: Year-over-year growth 2019 - 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition - Five forces 2019
• 22: Product - Market share 2019-2024 (%)
• 23: Comparison by Product
• 24: Standalone SPECT - Market size and forecast 2019-2024 ($ million)
• 25: Standalone SPECT - Year-over-year growth 2019-2024 (%)
• 26: Hybrid SPECT - Market size and forecast 2019-2024 ($ million)
• 27: Hybrid SPECT - Year-over-year growth 2019-2024 (%)
• 28: Market opportunity by Product
• 29: Application - Market share 2019-2024 (%)
• 30: Comparison by Application
• 31: Cardiology - Market size and forecast 2019-2024 ($ million)
• 32: Cardiology - Year-over-year growth 2019-2024 (%)
• 33: Oncology - Market size and forecast 2019-2024 ($ million)
• 34: Oncology - Year-over-year growth 2019-2024 (%)
• 35: Neurology - Market size and forecast 2019-2024 ($ million)
• 36: Neurology - Year-over-year growth 2019-2024 (%)
• 37: Others - Market size and forecast 2019-2024 ($ million)
• 38: Others - Year-over-year growth 2019-2024 (%)
• 39: Market opportunity by Application
• 40: Customer landscape
• 41: Market share by geography 2019-2024 (%)
• 42: Geographic comparison
• 43: North America - Market size and forecast 2019-2024 ($ million)
• 44: North America - Year-over-year growth 2019-2024 (%)
• 45: Europe - Market size and forecast 2019-2024 ($ million)
• 46: Europe - Year-over-year growth 2019-2024 (%)
• 47: Asia - Market size and forecast 2019-2024 ($ million)
• 48: Asia - Year-over-year growth 2019-2024 (%)
• 49: ROW - Market size and forecast 2019-2024 ($ million)
• 50: ROW - Year-over-year growth 2019-2024 (%)
• 51: Key leading countries
• 52: Market opportunity by geography ($ million)
• 53: Impact of drivers and challenges
• 54: Vendor landscape
• 55: Landscape disruption
• 56: Industry risks
• 57: Vendors covered
• 58: Market positioning of vendors
• 59: Bruker Corp. - Overview
• 60: Bruker Corp. - Business segments
• 61: Bruker Corp. - Key offerings
• 62: Bruker Corp. - Key customers
• 63: Bruker Corp. - Segment focus
• 64: DDD-Diagnostic AS - Overview
• 65: DDD-Diagnostic AS - Product and service
• 66: DDD-Diagnostic AS - Key offerings
• 67: DDD-Diagnostic AS - Key customers
• 68: DDD-Diagnostic AS - Segment focus
• 69: Digirad Corp. - Overview
• 70: Digirad Corp. - Business segments
• 71: Digirad Corp. - Key offerings
• 72: Digirad Corp. - Key customers
• 73: Digirad Corp. - Segment focus
• 74: General Electric Co. - Overview
• 75: General Electric Co. - Business segments
• 76: General Electric Co. - Key offerings
• 77: General Electric Co. - Key customers
• 78: General Electric Co. - Segment focus
• 79: Koninklijke Philips NV - Overview
• 80: Koninklijke Philips NV - Business segments
• 81: Koninklijke Philips NV - Key offerings
• 82: Koninklijke Philips NV - Key customers
• 83: Koninklijke Philips NV - Segment focus
• 84: Mediso Ltd. - Overview
• 85: Mediso Ltd. - Product and service
• 86: Mediso Ltd. - Key offerings
• 87: Mediso Ltd. - Key customers
• 88: Mediso Ltd. - Segment focus
• 89: MiE GmbH - Overview
• 90: MiE GmbH - Product and service
• 91: MiE GmbH - Key offerings
• 92: MiE GmbH - Key customers
• 93: MiE GmbH - Segment focus
• 94: MILabs BV - Overview
• 95: MILabs BV - Product and service
• 96: MILabs BV - Key offerings
• 97: MILabs BV - Key customers
• 98: MILabs BV - Segment focus
• 99: Siemens Healthineers AG - Overview
• 100: Siemens Healthineers AG - Business segments
• 101: Siemens Healthineers AG - Key offerings
• 102: Siemens Healthineers AG - Key customers
• 103: Siemens Healthineers AG - Segment focus
• 104: Spectrum Dynamics Medical Inc. - Overview
• 105: Spectrum Dynamics Medical Inc. - Product and service
• 106: Spectrum Dynamics Medical Inc. - Key offerings
• 107: Spectrum Dynamics Medical Inc. - Key customers
• 108: Spectrum Dynamics Medical Inc. - Segment focus
• 109: Currency conversion rates for US$
• 110: Research Methodology
• 111: Validation techniques employed for market sizing
• 112: Information sources
• 113: List of abbreviations

Companies Mentioned
. Bruker Corp.
. DDD-Diagnostic AS
. Digirad Corp.
. General Electric Co.
. Koninklijke Philips NV
. Mediso Ltd.
. MiE GmbH
. MILabs BV
. Siemens Healthineers AG
. Spectrum Dynamics Medical Inc.